A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)
Objective: Vortioxetine is a monoaminergic drug with a novel multimodal mechanism of action. We investigated its efficacy on depressive symptoms, cognitive function, and quality of life among cancer patients.Methods: In this multicenter, open-label, single-arm, observational study, patients received...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Asian Pacific Journal of Cancer Prevention (APJCP)
2023
|
Subjects: | |
Online Access: | http://ir.unimas.my/id/eprint/42713/3/A%206-Month.pdf http://ir.unimas.my/id/eprint/42713/ https://journal.waocp.org/?sid=Entrez:PubMed&id=pmid:37642043&key=2023.24.8.2583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|